Methane

Methane

SCHEMBL23966331

C.CCCCc1c(F)c(OC)cc(OC)c1CC

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 9/20 0.40
PDE3B Q13370 3/20 0.36
PDE3A Q14432 3/20 0.36
HMGCR P04035 1/20 0.35
PTGS2 P35354 3/20 0.33
SMPD3 Q9NY59 1/20 0.33
NPC1 O15118 1/20 0.33
HPGD P15428 1/20 0.33
MAPK1 P28482 1/20 0.33
HTT P42858 1/20 0.33
RAB9A P51151 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
PPARG P37231 1/20 0.33
PPARD Q03181 1/20 0.33
PPARA Q07869 1/20 0.33
HTR2A P28223 1/20 0.32
TYR P14679 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17522163 0.80 PTGS2 (0.41) ALOX5PDE3BPDE3AHMGCRPTGS2
SCHEMBL17522164 0.76 HMGCR (0.47) ALOX5PDE3BPDE3AHMGCRPTGS2
SCHEMBL21280424 0.72 HMGCR (0.53) ALOX5PDE3BPDE3AHMGCRPTGS2
SCHEMBL5141831 0.72 ACHE (0.48) ALOX5PTGS2SMPD3NPC1HPGD
SCHEMBL18781430 0.72 KDM4E (0.36) PDE3BPDE3AHMGCRPTGS2NPC1
SCHEMBL27947309 0.71 NPC1 (0.48) ALOX5PTGS2NPC1HPGDMAPK1
SCHEMBL19363655 0.70 CNR2 (0.35) PDE3BPDE3AHMGCRPTGS2HTR2A
SCHEMBL28042367 0.69 ALOX5 (0.41) ALOX5PDE3BPDE3AHMGCRPTGS2
SCHEMBL10752271 0.68 ALOX5 (0.44) ALOX5PTGS2NPC1HPGDMAPK1
SCHEMBL22035471 0.68 PTGS2 (0.41) PDE3BPDE3AHMGCRPTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3353164-B1 BI-HETEROARYL SUBSTITUTED 1,4-BENZODIAZEPINES AND USES THEREOF FOR THE TREATMENT OF CANCER JANSSEN PHARMACEUTICA NV (BE) 2021-11-03 EP disclosed